West R, McNeill A, Raw M. (2000). Smoking cessation guidelines for health professionals: an update. Thorax 55:987-999

The blueprint for the UK’s national network of stop-smoking services that has informed the delivery of these services for more than 20 years.

Elander J, West R, French D. (1993). Behavioral correlates of individual differences in road-traffic crash risk: An examination of methods and findings. Psychological Bulletin, 113(2), 279–294. https://doi.org/10.1037/0033-2909.113.2.279

A comprehensive account of what leads different drivers to be more at risk of crashing their cars.

West R. and Brown J. (2013). Theory of addiction. Chichester: John Wiley & Sons.

An integrative theory of motivation, the PRIME Theory, and its application to understanding and combating addiction.

West R., Hajek P., Stead L. and Stapleton J. (2005), Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction, 100: 299-303. https://doi.org/10.1111/j.1360-0443.2004.00995.x

A standard set of criteria for assessing outcomes in smoking cessation trials.

West R, Sohal T. (2006) “Catastrophic” pathways to smoking cessation: findings from national survey. BMJ Feb 25;332(7539):458-60. doi: 10.1136/bmj.38723.573866.AE.

Evidence that smokers who try to quit without any pre-planning, as predicted by the PRIME Theory of motivation, are at least as likely to succeed as those who plan ahead; a nail in the coffin of the stages of change model of behaviour change.

Fidler, J.A., Shahab, L. and West, R. (2011), Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerström Test for Nicotine Dependence and its components. Addiction, 106: 631-638. https://doi.org/10.1111/j.1360-0443.2010.03226.x

Evidence that a simple single-item rating based on the PRIME Theory of motivation can act as at least as good a measure of cigarette addiction as the multi-item scale most commonly used.

Michie, S., van Stralen, M.M. & West, R. (2011) The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Sci 6, 42.

First description of a general model of behaviour, the COM-B Model and a framework, the Behaviour Change Wheel, for developing behaviour change interventions using this model.

West R, Zatonski W, Cedzynska M, Lewandowska D, Pazik J, Aveyard P, Stapleton J. (2011) Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. Sep 29;365(13):1193-200. doi: 10.1056/NEJMoa1102035. PMID: 21991893.

Important evidence that the drug, cytisine, is effective in aiding quit attempts.

Anthenelli RM, Benowitz NL, West R, St Aubin L, McRae T, Lawrence D, Ascher J, Russ C, Krishen A, Evins AE. (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet. Jun 18;387(10037):2507-20. doi: 10.1016/S0140-6736(16)30272-0. Epub 2016 Apr 22. PMID: 27116918.

Important evidence on the efficacy and safety of the smoking cessation drug, varenicline, contributed to the US FDA removing a black box safety warning on the drug.

Michie S, Atkins L, West R (2014) The behaviour change wheel A guide to designing interventions. Great Britain: Silverback Publishing.

A handbook for people wishing to develop behaviour change interventions using the COM-B model and the Behaviour Change Wheel framework.